To evaluate the clinical value of iodine -LSB- @I -RSB- metuximab infusion combined with transcatheter arterial chemoembolization ( TACE ) for treating cases of post-intervention relapse of mid or advanced stage hepatocellular carcinoma ( HCC ) .